Immunosuppression and Human Malignancy: Contemporary Immunology
Autor David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohanen Limba Engleză Paperback – 30 sep 2011
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 694.88 lei 43-57 zile | |
Humana Press Inc. – 30 sep 2011 | 694.88 lei 43-57 zile | |
Hardback (1) | 701.65 lei 43-57 zile | |
Humana Press Inc. – 5 ian 1990 | 701.65 lei 43-57 zile |
Preț: 694.88 lei
Preț vechi: 731.45 lei
-5% Nou
Puncte Express: 1042
Preț estimativ în valută:
132.100€ • 138.62$ • 110.72£
132.100€ • 138.62$ • 110.72£
Carte tipărită la comandă
Livrare economică 06-20 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781461288466
ISBN-10: 1461288460
Pagini: 288
Ilustrații: XII, 272 p.
Dimensiuni: 155 x 235 x 15 mm
Greutate: 0.41 kg
Ediția:1989
Editura: Humana Press Inc.
Colecția Humana
Seria Contemporary Immunology
Locul publicării:Totowa, NJ, United States
ISBN-10: 1461288460
Pagini: 288
Ilustrații: XII, 272 p.
Dimensiuni: 155 x 235 x 15 mm
Greutate: 0.41 kg
Ediția:1989
Editura: Humana Press Inc.
Colecția Humana
Seria Contemporary Immunology
Locul publicării:Totowa, NJ, United States
Public țintă
ResearchCuprins
Induction of Suppressor Cells by Immunostimulants.- 1. Introduction.- 2. Induction of Suppressor Cells by BCG.- 3. Induction of Suppressor Cells by C. parvum and Other Immunostimulants.- 4. Conclusions.- Control of Natural Killer Cells by Suppressor Cells.- 1. Introduction.- 2. Activity of Anti-NK Suppressor Cells in Normal Animals.- 3. Activation of Anti-NK Suppressor Cells by Irradiation or Treatment with Estrogen.- 4. Activation of Anti-NK Suppressor Cells by External Stimulators.- 5. Activity of Anti-NK Suppressor Cells in TBH.- 6. Mechanisms.- 7. Suppression or Artifact?.- 8. Suppressor Cells Controlling NK-Cell Activity in Human Beings.- Antigenic Entities of the Tumor That Induce Suppressor Cells May Prevent the Potentiation of Coexpressed Immunogenic Entities.- Suppressor Cells in Human Malignant Diseases.- 1. Introduction.- 2. Hodgkin’s Disease.- 3. Non-Hodgkin’s Lymphomas, Leukemias, and Multiple Myelomas.- 4. Cancer of the Head and Neck.- 5. Lung Cancer.- 6. Alimentary-Tract Malignancies.- 7. Genitourinary Malignancies.- 8. Gynecologic Malignancies.- 9. Cancer of the Breast.- 10. Melanoma and Other Skin Malignancies.- 11. Malignancies of the Central Nervous System.- 12. Some Considerations of the Role of Immune Suppression in Human Malignancy.- 13. The Effect of Antineoplastic Chemotherapy on Human Suppressor-Cell Activity.- Suppressor Cells and Malignancy in Animal Experimental Models: A Brief Summary of Recent Findings.- 1. Suppressor Macrophages and “Null” Cells.- 2. “Sneaking Through” of Low Doses of Tumor Cells Is Mediated by Suppressor Cells.- 3. Suppressor T Cells and Their Mechanism of Action.- 4. Suppressor T Cell Lines and Clones.- 5. Suppression of Concomitant Immunity.- 6. Immunotherapy Based on Suppressor Cells Eradication.- 7.Immunoregulation of Antitumor Autoimmunity by Suppressor T Cells.- General Conclusions.- References.